Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
7h agoPony.ai Announces New Generation Autonomous Driving Compute Platform Built on NVIDIA DRIVE Hyperion
15h agoIFS announces filing of 2025 Annual Report on Form 20-F
15h agoRelated Digital Announces Financing for $16 Billion Oracle Data Center Project in Saline Township, Michigan
15h agoQuesterre Energy Corporation Issues Clarification to Press Release from April 24, 2026
15h agoArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of March 2026

Eupraxia Pharmaceuticals Inc

About

Eupraxia Pharmaceuticals Inc (TO:EPRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
Apr 21 2026
Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis 
Apr 13 2026
Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences
Mar 17 2026
Eupraxia Pharmaceuticals Reports Six-Month Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis
Mar 13 2026
Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

Financials

Revenue
CA$0
Market Cap
CA$611.96 M
EPS
-1.43

Community Chat

Ask AI

6ix6ixAIEvents